Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations.
Int J Mol Sci. 2021 Jun 11;22(12):6288. doi: 10.3390/ijms22126288.
Int J Mol Sci. 2021.
PMID: 34208111
Free PMC article.
Review.